As shown in Fig7C, CCR9− M579-A2 tumors grew significantly slower than the CCR9+ tumors in response to the adoptive T cell transfer, indicating that CCR9 suppresses the anti-tumor activity of the transferred T cells in vivo as well. This evidence concerns the gene CCR9 and neoplasm.